|
IPHAF
|
My only disappointment so far with this deal is Foster comes with it, as...
|
|
IPHAF
|
Volcosporin has been tested for the most part at .4mg, therefore I find...
|
|
IPHAF
|
looks like this drugs primary usage will not be for renal ---- still looks...
|
|
IPHAF
|
Extremely low volume here and dollar amount, nothing to get to excited about...
|
|
IPHAF
|
So far MacDougall is happy to buy.
|
|
IPHAF
|
more information from other trials? Why not put current trial information out...
|
|
IPHAF
|
Looks bad...even the nudge nudge wink wink people aren't buying. Pretty...
|
|
IPHAF
|
Apparently we have to wait till April for a clue to our company’s future. The...
|
|
IPHAF
|
Isotechnika also has a phase three trial coming to an end so data ...
|
|
IPHAF
|
Thank goodness someone is able to sell theirs shares at well over $5, I was...
|
|
IPHAF
|
Looks like we have to wait to the last minute of the last hour before...
|
|
IPHAF
|
Stock price indicates a poor deal or no deal on the horizon. I think Foster...
|
|
IPHAF
|
This is interesting from a pill perspective.
http://www.bloomberg.com/apps...
|
|
IPHAF
|
Teevee has flipped a couple of times over the years he was wrongthen.
|
|
IPHAF
|
We have sold the company, this is what I'm hoping for in the...
|
|
IPHAF
|
News should be out shortly and I don't think a deal needs to be done for...
|
|
IPHAF
|
Someone is telling us to buy, problem is were all afraid. teevee are you...
|
|
IPHAF
|
This far along and nothing
|
|
IPHAF
|
Douglas Loe has given up on covering this company, wonder what that means...
|
|
IPHAF
|
David Martin has upgraded to neutral and there's a new presentation on...
|